Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farah Al-Fatyan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Immunotherapy Advances|April 23, 2025
CTLA-4-two pathways to anti-tumour immunity?Frank J Ward, Paul T Kennedy, Farah Al-Fatyan, et al.
Cancers|March 29, 2023
A Novel Role for the Soluble Isoform of CTLA-4 in Normal, Dysplastic and Neoplastic Oral and Oropharyngeal EpitheliaPrarthna Clare, Farah Al-Fatyan, Badri Risheh, et al.
Journal of Cellular Physiology|February 13, 2025
Molecular Mechanisms and Therapeutic Implications of Long Non-coding RNAs in Cutaneous Biology and DiseaseAlessandro Zuccotti, Farah Al-Fatyan, Giulia D S Ferretti, et al.
Frontiers in Immunology|January 24, 2022
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant MelanomaRahul C Khanolkar, Chu Zhang, Farah Al-Fatyan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Immunotherapy Advances|April 23, 2025
CTLA-4-two pathways to anti-tumour immunity?Frank J Ward, Paul T Kennedy, Farah Al-Fatyan, et al.
Cancers|March 29, 2023
A Novel Role for the Soluble Isoform of CTLA-4 in Normal, Dysplastic and Neoplastic Oral and Oropharyngeal EpitheliaPrarthna Clare, Farah Al-Fatyan, Badri Risheh, et al.
Journal of Cellular Physiology|February 13, 2025
Molecular Mechanisms and Therapeutic Implications of Long Non-coding RNAs in Cutaneous Biology and DiseaseAlessandro Zuccotti, Farah Al-Fatyan, Giulia D S Ferretti, et al.
Frontiers in Immunology|January 24, 2022
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant MelanomaRahul C Khanolkar, Chu Zhang, Farah Al-Fatyan, et al.
Pageof 1